Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

Florbetaben Phase 3 Study Group

Research output: Contribution to journalArticle

182 Scopus citations

Abstract

Abstract Background Evaluation of brain β-amyloid by positron emission tomography (PET) imaging can assist in the diagnosis of Alzheimer disease (AD) and other dementias. Methods Open-label, nonrandomized, multicenter, phase 3 study to validate the 18F-labeled β-amyloid tracer florbetaben by comparing in vivo PET imaging with post-mortem histopathology. Results Brain images and tissue from 74 deceased subjects (of 216 trial participants) were analyzed. Forty-six of 47 neuritic β-amyloid-positive cases were read as PET positive, and 24 of 27 neuritic β-amyloid plaque-negative cases were read as PET negative (sensitivity 97.9% [95% confidence interval or CI 93.8-100%], specificity 88.9% [95% CI 77.0-100%]). In a subgroup, a regional tissue-scan matched analysis was performed. In areas known to strongly accumulate β-amyloid plaques, sensitivity and specificity were 82% to 90%, and 86% to 95%, respectively. Conclusions Florbetaben PET shows high sensitivity and specificity for the detection of histopathology-confirmed neuritic β-amyloid plaques and may thus be a valuable adjunct to clinical diagnosis, particularly for the exclusion of AD. Trial registration ClinicalTrials.gov NCT01020838.

Original languageEnglish (US)
Article number1958
Pages (from-to)964-974
Number of pages11
JournalAlzheimer's and Dementia
Volume11
Issue number8
DOIs
StatePublished - Aug 1 2015

Keywords

  • Amyloid
  • Florbetaben
  • Histopathology
  • PET

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study'. Together they form a unique fingerprint.

  • Cite this